Reactive astrocytes induced by ischemia can transdifferentiate into mature neurons. This neurogenic potential of astrocytes may have therapeutic value for brain injury. Epigenetic modifications are widely known to involve in developmental and adult neurogenesis. PAX6, a neurogenic fate determinant, contributes to the astrocyte-to-neuron conversion. However, it is unclear whether microRNAs (miRs) modulate PAX6-mediated astrocyte-to-neuron conversion. In the present study we used bioinformatic approaches to predict miRs potentially targeting Pax6, and transient middle cerebral artery occlusion (MCAO) to model cerebral ischemic injury in adult rats. These rats were given striatal injection of glial fibrillary acidic protein targeted enhanced green fluorescence protein lentiviral vectors (Lv-GFAP-EGFP) to permit cell fate mapping for tracing astrocytes-derived neurons. We verified that miR-365 directly targets to the 3 0 -UTR of Pax6 by luciferase assay. We found that miR-365 expression was significantly increased in the ischemic brain. Intraventricular injection of miR-365 antagomir effectively increased astrocytic PAX6 expression and the number of new mature neurons derived from astrocytes in the ischemic striatum, and reduced neurological deficits as well as cerebral infarct volume. Conversely, miR-365 agomir reduced PAX6 expression and neurogenesis, and worsened brain injury. Moreover, exogenous overexpression of PAX6 enhanced the astrocyte-to-neuron conversion and abolished the effects of miR-365. Our results demonstrate that increase of miR-365 in the ischemic brain inhibits astrocyte-to-neuron conversion by targeting Pax6, whereas knockdown of miR-365 enhances PAX6-mediated neurogenesis from astrocytes and attenuates neuronal injury in the brain after ischemic stroke. Our findings provide a foundation for developing novel therapeutic strategies for brain injury.
2014), and reform neural circuitry with preexisting neurons in the ischemic regions of adult rat brain (Duan et al., 2015) . These observations indicate that neurogenesis from ischemia-induced reactive astrocytes might play important roles in neural repair following ischemic brain injury.
PAX6, a key transcription factor in the generation of neuronal lineages in the central nervous system (CNS; Hack et al., 2005; Hack, Sugimori, Lundberg, Nakafuku, & Gotz, 2004; Kallur, Gisler, Lindvall, & Kokaia, 2008; Manuel, Mi, Mason, & Price, 2015) , can direct the astrocyte-to-neuron conversion. For example, forced expression of PAX6 induces cultured astrocytes conversion into neurons (Heins et al., 2002) . Additionally, PAX6 overexpression causes reactive astrocytes to express the early neuronal markers in the cortex of mouse with a cortical stab wound lesion (Buffo et al., 2005) and transdifferentiate into neuroblasts in the ischemic brain (Kronenberg et al., 2010) .
These studies suggest that upregulation of PAX6 might be beneficial for promoting astrocyte-to-neuron conversion in the brain after ischemic injury.
MicroRNAs (miRs) are small (22 nt) non-coding RNAs that bind to the 3 0 -UTR of target mRNA and result in mRNA degradation or translational repression. MiRs participate in a wide variety of cellular processes, such as cell proliferation, differentiation, metabolism, and fate determination (Bartel, 2007; Carthew & Sontheimer, 2009; Li & Jin, 2010; Singh, 2007) . Moreover, miRs mediate reprogramming of somatic cells into neural stem cells or neurons (Yang et al., 2017) . Under pathological condition, miRs alter in the ischemic brain (Bhalala, Srikanth, & Kessler, 2013; Wu, Zuo, & Ji, 2012; Zhou, Ding, & Gu, 2016) and modulate ischemia-induced neurogenesis in adult rat brain via notch and sonic hedgehog signaling pathways (Liu, Chopp, Zhang, & Zhang, 2013) . It has been reported that miRs regulate adult neurogenesis by targeting multiple transcription factors (Shibata, Nakao, Kiyonari, Abe, & Aizawa, 2011) .
Therefore, we proposed that miRs might regulate the conversion of astrocytes into neurons via directing PAX6 expression in the brain after ischemic stroke.
In the present study, we used bioinformatic approaches to identify miRs which have potential binding sites in the 3 0 -UTR of Pax6 and transient middle cerebral artery occlusion model to induce ischemic brain injury and striatal injection of lentiviral-GFAP-EGFP vectors combined with cell fate mapping to trace the transition of astrocytes into neurons. We mainly found that miR-365 inhibited ischemia-induced astrocyte-to-neuron conversion by targeting Pax6 and knockdown of miR-365 enhanced the PAX6-mediated astrocytes-derived neurogenesis in the rat brain after ischemic injury.
| M A TE RI A L S A ND M E TH ODS

| Prediction and synthesis of miRs targeting Pax6
MiRs targeting the 3 0 -UTR of Pax6 were predicted using TargetScan, miRDB and microRNA.org. Candidate miRs were selected based on their prediction by all three bioinformatic tools, and were conserved in human, mouse and rat. MiR agomir and antagomir oligonucleotides were synthesized and purified with high-performance liquid chromatography by Shanghai GenePharma Co. Ltd. (Shanghai, China). All miR oligonucleo- 
| Primary cortical astrocyte culture and miR transfection
Cortical astrocytes were obtained from newborn Sprague Dawley rats (1-3 days old). Briefly, after removal of blood vessels and pia mater, cerebral cortices were digested with 0.25% trypsin (Gibco, Rockville, MD, USA) at 378C for 10 min, and dissociated cortical cells were suspended in DMEM (Gibco, Rockville, MD, USA) with 10% fetal bovine serum (FBS; Biological Industries, Cromwell, CT, USA). The cells were then passed through a 70 lm mesh (BD Biosciences, USA) and plated at a density of 1 3 10 6 cells/ml on poly-L-lysine (0.1 mg/ml; Sigma-Aldrich, St. Louis, MO, USA)-coated dishes in high-glucose DMEM with 10% FBS and antibiotics (100 U/ml penicillin 1 100 lg/ml streptomycin; Gibco, Rockville, MD, USA) in a 5% CO 2 humidified incubator at 378C. The culture medium was changed every 3 days. Cells were passaged upon reaching 90% confluence.
Astrocytes were identified with glial fibrillary acidic protein (GFAP) immunolabeling and were used for experiments when the number of GFAPpositive cells exceeded 95% of the total. Cultured astrocytes were transfected with 50 nM agomir or antagomir or negative-control (GenePharma; Ma et al., 2016 ) using lipofectamine 2000 according to the manufacturer's protocol. The cells were harvested at 48 hr after transfection for further detection of miRs, mRNAs and proteins.
| qRT-PCR analysis
MiRs and mRNAs were extracted using the miRcute miR extraction kit (Tiangen) and Trizol reagent (Invitrogen) according to the manufacturers' protocols. Reverse transcription of miR was performed using the
One
Step miR cDNA Synthesis Kit (HaiGene, Haerbin, China), and reverse transcription of mRNA was performed using the Golden 1st cDNA Synthesis Kit (HaiGene). PCR amplification was performed on the Eppendorf Mastercycler ep realplex (Eppendorf UK Limited, UK) using the Golden HS SYBR Green qPCR Mix Kit (HaiGene). MiR and mRNA levels were normalized to RNU6B small RNA and actin, respectively. Comparisons were calculated as the reverse log of the DDCT from controls (Pfaffl, 2001 
| Oxygen and glucose deprivation
Oxygen and glucose deprivation (OGD) was induced as previously described (Wu, Kou, Mo, Deng, & Sun, 2016) . Briefly, cultured astrocytes were washed and incubated in deoxygenated glucose-free DMEM (Gibco, Rockville, MD, USA). The cultures were then transferred to an anaerobic chamber filled with a gas mixture of 95% N 2 /5% CO 2 at 378C for 4 hr. At the end of OGD treatment, the medium was replaced with normal medium, and the cultures were returned to a normal atmosphere.
Control cells were cultured under normoxic conditions without OGD treatment. With this condition, we harvested the cells at 1, 6, 12, and 24 hr after OGD treatment for the detection of miRs and proteins.
| Luciferase assay
The full-length rat Pax6 3 . We used primers 1 and 3 or 2 and 4 to amplify from primary rat astrocyte cDNA to acquire PCR products A or B, respectively. Then, we used primers 1 and 2 to amplify from a mixture of PCR products A and B to obtain the mutant sequence. The wild-type or mutant 3 0 -UTR of Pax6 was then inserted into the XhoI and NotI sites downstream of the humanized renilla luciferase gene in the psiCHECK-2 vector (Promega) and confirmed by DNA sequencing (BioSune, Shanghai, China).
293T cells were purchased from the Cell Bank of the Chinese Academy of Sciences and seeded onto 24-well plates 1 day before transfection. The wells were 50%-70% confluent on the day of transfection and were cotransfected with 200 ng reporter vector carrying the Pax6 wild-type or mutant 3 0 -UTR and 50 nM miR agomir or negative control per well using lipofectamine 2000 according to the manufacturer's protocol. At 48 hr after transfection, the cells were lysed, and extracted proteins were assayed using a dual luciferase reporter assay system, E1910 (Promega), according to the manufacturer's protocol.
Results were expressed as relative luciferase activity, while renilla luciferase activity was normalized to firefly luciferase activity.
| Animals
Male Sprague Dawley rats (230-260 g) were purchased from the Shanghai Experimental Animal Center of the Chinese Academy of Sciences. 
| Stereotactic virus injection
Lenti-GFAP-EGFP virus (Lv-GFAP-EGFP; containing the astrocytespecific GFAP promoter; 1 3 10 8 TU/ml; GeneChem, Shanghai China)
and Lenti-Pax6-mCherry virus (Lv-Pax6; containing the rat Pax6 CDS; 2 3 10 8 TU/ml; GeneChem) were used to label astrocytes and overexpress PAX6, respectively. Lenti-mCherry virus (Lv-mCherry; 1 3 10 9 TU/ml; GeneChem) was used as the control for Lv-Pax6. The injection volumes for Lv-GFAP-EGFP, Lv-Pax6 and Lv-mCherry were 2, 2.5, and 0.5 ll, respectively. Seven days before subjecting to the operation of middle cerebral artery occlusion (MCAO), the same animals were injected with a viral suspension in the ipsilateral striatum (Bregma: AP, 11.0 mm; ML, 12.5 mm; DV, 24.0 mm). The injection rate was 0.19 ll/min, and the glass pipette was left in place for an additional 15 min before being withdrawn at a rate of 1 mm/min.
| Operation of MCAO
Animals were anesthetized with 10% chloral hydrate (360 mg/kg, i.p.).
Arterial blood pO 2 , pCO 2 and pH were monitored using an i-STAT Analyzer (Abbott Laboratories, Chicago, USA). The rectal temperature was maintained at 378C 6 0.58C using a temperature-regulated heat lamp (Wang, Guo, Qiu, Feng, & Sun, 2007) . Rats with physiological variables within normal ranges were subjected to a left MCAO as described previously (Zhang et al., 2006) . Briefly, a 4-0 nylon monofilament with a rounded tip was introduced into the lumen of the left external carotid artery and gently advanced into the internal carotid artery until a slight resistance was felt. The filament was left in place for 30 min and then withdrawn.
| pGfa2-EGFP plasmid and miR injection
The pGfa2-EGFP plasmid was generated as described previously (Shen et al., 2016) . Within 30 min of reperfusion after MCAO, stereotaxic injection of the plasmid was performed in deeply anesthetized rats placed in a stereotaxic frame. A 3 ll volume of the plasmid mixture (1 ll of 5 lg/ll plasmid, 1 ll of sterile saline and 1 ll of lipofectamine 2000) was stereotaxically delivered into the ipsilateral striatum (Bregma: AP, 11.0 mm; ML, 12.5 mm; DV, 24.0 mm). The injection rate was 0.19 ll/min, and the glass pipette was left in the place for an additional 15 min before being withdrawn at a rate of 1 mm/min. The miR agomir, antagomir and negative controls were diluted to a final concentration of 100 lM for intracerebroventricular infusion (Ge et al., 2014; Ma et al., 2016; Tao et al., 2015) . MiR oligomers (5 ll) were then combined with lipofectamine 2000 (5 ll) in an RNase-free PCR tube and incubated for at least 20 min at room temperature. The total injection volume of 10 ll was <5% of the 580 ll average cerebral spinal fluid volume in rats, and was therefore unlikely to cause intracranial hypertension (Lai, Smith, Lamm, & Hildebrandt, 1983 
| Neurological score measurement
Neurological deficits were assessed and scored according to Longa's five-point scale method (Longa, Weinstein, Carlson, & Cummins, 1989) .
Briefly, the following grading system was applied: grade 0, no observable neurological deficit; grade 1, failure to extend right forepaw fully; grade 2, circling to right; grade 3, falling to right; grade 4, unable to walk spontaneously. The average of neurological score for each group was used to express the severity of neurological deficits. The higher scores reflect the severer function deficits.
2.11 | 5 0 -Bromodeoxyuridine (BrdU) injection
To detect newborn neurons, we intraperitoneally injected freshly prepared BrdU (Sigma-Aldrich, St. Louis, MO, USA) in rats at a concentration of 50 mg/kg body weight once daily, 4-6 days after MCAO (Zhang et al., 2006) .
| Western blotting analysis
The protein samples were subjected to 10% sodium dodecyl sulfate 
| Brain section preparation
Rats were anesthetized with 10% chloral hydrate and transcardially perfused with 0.9% saline solution followed by 4% paraformaldehyde dissolved in 0.1 M phosphate-buffer (pH 7.4). The brains were removed, postfixed for 4 hr in 4% paraformaldehyde, and cryoprotected using a graded sucrose series (20% and 30%) until they sank. A freezing microtome (Model 820-II; Leica, Germany) was used to cut 30-lm-thick coronal sections. Sections were stored at 2208C in a cryoprotectant solution for histological analysis.
2.14 | Fluoro-Jade B staining
Brain sections were dried and dipped in an 80% ethanol solution containing 1% sodium hydroxide for 5 min, 70% ethanol for 2 min, and 0.06% potassium permanganate for 10 min. After rinsing with distilled water, the sections were incubated with Fluoro-Jade B (Millipore, Billerica, MA, USA) solution at concentration of 4 mg/L containing 0.1% acetic acid for 20 min (Zhang et al., 2006) . The signals of Fluoro-Jade B staining were detected at an excitation of 480 nm and an emission of 525 nm under a fluorescence microscope. Infarct area, contralateral hemisphere area and ipsilateral hemisphere area were measured using Image J software, and areas were multiplied by the distance between sections to obtain the respective volumes. Infarct volume was calculated as a percentage of the contralateral hemisphere volume, as described previously (Swanson et al., 1990 ).
| Immunohistochemical staining
For single labeling, brain sections were incubated with anti-rabbit PAX6
( 
| Statistical analysis
Statistical analysis was performed using GraphPad Prism software (Version 6.0). Statistical significance was determined either by unpaired two-tailed Student's t test for comparisons between two groups or by one-way ANOVA with Tukey's post-hoc test for multiple group comparisons. All experiments were repeated at least three times, and representative experiments are shown. All results are given as the means 6 SEM. Results were considered statistically significant at a p value of <0.05.
| R E SU LTS
3.1 | MiR-365 is upregulated in the ischemic brain and hypoxic cultured astrocytes
To investigate the regulation of Pax6 by miRs, we used three bioinformatic programs (TargetScan, miRDB and microRNA.org) to identify miRs that potentially bind the 3 0 -UTR of Pax6. MiR-365-3p (miR-365), miR-7a-5p (miR-7) and miR-129-5p (miR-129) have potential binding sites in the 3 0 -UTR of Pax6 ( Figure 1a) . Next, we designed specific agomirs for miR-365 (miR-365-ago), miR-7 (miR-7-ago) and miR-129 (miR-129-ago) to overexpress these miRs in cultured astrocytes (Figure 1b ).
We next assessed the effect of each miR on PAX6 protein expression.
MiR-365-ago significantly inhibited PAX6 expression, while miR-7-ago and miR-129-ago had no effect on PAX6 protein levels compared with agomir negative control (ago-nc; Figure 1c ,d).
Then, we examined the levels of these miRs in the ischemic rat striatum at several timepoints after MCAO. MiR-365 was upregulated, while miR-7 and miR-129 were downregulated in the ipsilateral striatum of rats at 24, 48, and 72 hr after MCAO compared with that in sham-operated rats (Figure 1e ). In addition, we performed an OGDreperfusion hypoxic treatment in cultured astrocytes. In consistent with the in vivo study, hypoxic treatment increased the levels of miR-365, while it decreased the levels of miR-7 and miR-129 in cultured astrocytes at 1, 6, 12, and 24 hr after OGD-reperfusion (Figure 1f ). These results clearly indicate that ischemia causes miR-365 upregulation.
With the same condition, we examined the levels of PAX6 protein in cultured astrocytes. We found that OGD-reperfusion treatment significantly reduced PAX6 expression in cultured astrocytes at 6 and 12 hr after hypoxic stimulation compared with control treatment (Figure 1g ).
| MiR-365 directly modulates PAX6 expression in cultured astrocytes
To assess whether miR-365 directly targets the 3 0 -UTR of Pax6, we expression compared with the controls (Figure 2d-f) . These results suggest that miR-365 directly affects PAX6 expression in the astrocytes.
3.3 | MiR-365 knockdown increases PAX6 expression in the astrocytes of rat brain after MCAO
As described above, cerebral ischemia increased miR-365 levels in the brain, and miR-365 repressed PAX6 expression in the astrocytes.
Therefore, we further analyzed the effects of miR-365-ago and miR-365-antag on the expression of PAX6 in the rat brain after MCAO. The rats were subjected to sham operation or a 30-min period of MCAO (Injury-ctl). Following MCAO, the rats were given contralateral ventricular injection of ago-nc, miR-365-ago, antag-nc or miR-365-antag, and sacrificed 3 days after MCAO (Figure 3a,b) . We confirmed that miR-365-ago increased, while miR-365-antag decreased miR-365 levels in the ipsilateral striatum compared with ago-nc and antag-nc, respectively cytes 48 hr after transfection of their corresponding miR agomirs (ago) or agomir negative control (ago-nc). All miR expression levels were normalized to endogenous control U6 snRNA and relative to control (n 5 3). (c and d) Expression levels of PAX6 protein in cultured astrocytes 48 hr after transfection of miR-365-ago (365-ago), miR-7-ago (7-ago), miR-129-ago (129-ago), or ago-nc were analyzed by WB. All protein expression levels were normalized to endogenous control actin and relative to control (n 5 5). (e) qRT-PCR analysis of miR-365, miR-7 and miR-129 expression in the ipsilateral striatum at 24, 48, and 72 hr after ischemia-reperfusion (I-R) (n 5 3). (f) qRT-PCR analysis of miR-365, miR-7 and miR-129 expression in cultured astrocytes at 1, 6, 12, and 24 hr after OGD-reperfusion (O-R) (n 5 3). (g) Expression levels of PAX6 protein in cultured astrocytes at 1, 6, 12, and 24 hr after O-R were analyzed by western blotting (WB) (n 5 3). In e, f, and g, the p values are for comparisons versus the sham and control group, respectively; *p < .05, **p < .01, ***p < .001, and ****p < .0001 by unpaired two-tailed Student's t test. In b and d, **p < .01, ***p < .001, and ****p < .0001 by one-way ANOVA with Tukey's post-hoc test. The data are presented as the means 6 SEM MO ET AL. (Duan et al., 2015) . In the present study we used a matured neuronal marker to trace reactive astrocyte neurogenic fate. With this model, we investigated the role of miR-365 in the conversion of reactive astrocytes into mature neurons.
As shown in Figure 5a ,b, we injected Lv-GFAP-EGFP (a lentivirus with the astrocyte-specific GFAP promoter) into the ipsilateral striatum of rats 7 days before MCAO, and miR-365-ago or miR-365-antag or negative controls into the contralateral ventricle immediately following MCAO. We then sacrificed the rats 14 days after initiating ischemia.
First, we performed double immunolabeling for GFP and GFAP to confirm that Lv-GFAP-EGFP specifically labeled astrocytes in the normal brain ( Figure 5c ). Next, we performed immunofluorescent double labeling for GFP and NeuN. We found that 10.2% GFP 1 cells were become mature neurons in the Injury-ctl group (Figure 5d 3.6 | MiR-365 knockdown enhances neurogenesis and reduces brain damage in rat after MCAO
As mentioned above, inhibition of miR-365 enhanced the strokeinduced conversion of astrocytes into mature neurons. These new mature neurons derived from astrocytes can functionally integrate into neural networks (Duan et al., 2015) , which might contribute to brain repair after ischemic injury. Therefore, we next tested the effects of miR-365 on neurogenesis and brain repair after MCAO. The rats were subjected to sham operation or a 30-min period of MCAO (Injury-ctl).
Following MCAO, the rats were given contralateral ventricular injection of ago-nc, miR-365-ago, antag-nc or miR-365-antag, and sacrificed 14 days after MCAO (Figure 8a ). Meanwhile, we observed the effects of miR-365 on neurological function in the rats after ischemic brain injury. The results showed that miR-365-ago treatment deteriorated neurological deficits compared with ago-nc or vehicle (Injury-ctl) treatment (Figure 8b ). On the contrary, miR-365-antag treatment significantly reduced the severity of stroke-induced neurological deficits compared with antag-nc or vehicle (Injury-ctl) treatment (Figure 8b ).
Then, we performed double immunolabeling for BrdU and NeuN to label newly generated mature neurons in the brain sections of rats 14 days after MCAO. We found that miR-365-ago treatment significantly reduced the number of BrdU Astrocytes, as a major type of neural cells in the mammalian brain, play vital roles in the CNS under physiological (Allen & Barres, 2009; Alvarez, Katayama, & Prat, 2013; Dong & Benveniste, 2001; Kirischuk, Heja, Kardos, & Billups, 2016; Liu, Ni, & Sun, 2017) and pathophysiological conditions (Buffo, Rolando, & Ceruti, 2010) . For example, reactive astrocytes induced by ischemic injury can accelerate the formation of glial scars (Boda & Buffo, 2010) . However, astrocytes also promote neuronal survival and neurogenesis by releasing various growth factors after ischemic stroke (Liu, Teschemacher, & Kasparov, 2017; Okoreeh, Bake, & Sohrabji, 2017; Vaccarino et al., 2007) . Therefore, astrocytesbased therapies for stroke draw extensive attention of researchers (Li, Liu, Xin, & Chopp, 2014; Trendelenburg & Dirnagl, 2005) . Interestingly, in the ischemic brain, reactive astrocytes exhibit the properties of neural stem/progenitor cells (Gotz, Sirko, Beckers, & Irmler, 2015) and transdifferentiate into mature (Duan et al., 2015; Magnusson et al., 2014) and functional (Duan et al., 2015) neurons. In the present study,
we further confirmed such transdifferentiation of astrocytes in adult rat brain ( Figure 5d ). As we have known, only small populations of reactive astrocytes can convert into neurons and most of them become glial scar/astrogliosis. Theoretically, for promotion of brain repair after injury, one of important approaches could be to enhance the capacity of astrocyte-to-neuron conversion. PAX6 is an important factor to direct astroglial to neuronal lineages (Heins et al., 2002; Kronenberg et al., 2010) .We have reported that ischemic stroke induces expression of PAX6 in reactive astrocytes in adult rat brain, and vascular endothelial growth factor (VEGF) enhances PAX6-expressed astrocytes and the conversion of astrocyte-to-neuron (Shen et al., 2016) . The present study directly demonstrate that exogenous expression of PAX6 in the brain can enhance the capability of such conversion (Figure 6e ,f).
MiRs function in RNA silencing and post-translational regulation of gene expression. It has been reported that post-translation of Pax6 mRNA is regulated by miRs (Bhinge et al., 2016; de Chevigny et al., 2012) . To identify miRs targeting the Pax6 gene, we performed bioinformatics analysis to screen candidates, which revealed that miR-365, miR-7 and miR-129 have potential binding sites on the 3 0 -UTR ( Figure   1a ). We found that miR-365, but not miR-7 or miR-129, inhibited PAX6 expression in cultured astrocytes (Figure 1c,d) . However, previous studies have reported that miR-7 suppresses PAX6 expression in mouse and human (de Chevigny et al., 2012; Latreille et al., 2014; Needhamsen, White, Giles, Dunlop, & Thomas, 2014) . This discrepancy might be caused by species variation. Moreover, we of the ischemic rat brain (Dharap, Bowen, Place, Li, & Vemuganti, 2009 ). Besides, the expression relationship of miR-365 and PAX6 was negative correlation (Figure 1f,g ). Taken together, we found that miR-365 was increased in the ischemic brain and inhibited PAX6 expression in the astrocytes. Therefore, we focused on miR-365 for further in vivo investigations.
MiR-365 plays roles in the initiation and development of cancers by repressing bcl-2 and cyclin D1/cdc25A expression (Guo et al., 2013; Nie et al., 2012) . In addition, miR-365 participates in morphine (g) Infarct volume was calculated as a percentage of contralateral hemisphere volume (n 5 3 in the sham group; n 5 6 in the injury-ctl, ago-nc and 365-ago groups; n 5 10 in the antag-nc and 365-antag groups). *p < .05, **p < .01, ***p < .001, and ****p < .0001 by one-way ANOVA with Tukey's post-hoc test. The data are presented as the means 6 SEM [Color figure can be viewed at wileyonlinelibrary.com] tolerance and nociceptive behaviors (Pan et al., 2016; . Moreover, miR-365 is upregulated in the spinal cord of rats with amyotrophic lateral sclerosis and in the hippocampus of epileptic rats (Parisi et al., 2013; Sun et al., 2013) . However, the significance of this upregulation in the CNS remains unclear, although it has been reported that miR-365 increases apoptosis and inflammatory response (Qin et al., 2011; Yang et al., 2016) . In the present study we clearly demonstrate that ischemia upregulates miR-365 (Figure 1e,f) . An increase in endogenous miR-365 levels in the ischemic brain could aggravate neuronal damage because knockdown of miR-365 by its antagomir significantly reduced neurological deficits and ischemic infarct volume, and enhanced stroke-induced neurogenesis (Figure 8 ). Indeed, upregulation of miR-365 with its agomir had the opposite effects. Collectively, our results demonstrate that, in the ischemic brain, upregulation of miR-365 is detrimental to brain repair. Conversely, downregulation of miR-365 is beneficial. We speculate that the increase in infarct volume induced by miR-365 might be related to a reduction in neurogenesis.
Although miR-365 has been shown to repress bcl-2 expression in can- These results clearly demonstrate that miR-365 inhibits PAX6 expression by targeting the 3 0 -UTR.
PAX6 is a pro-neurogenic transcription factor and highly expresses in reactive astrocytes following ischemia (Duan et al., 2015; Steliga et al., 2013) , and it plays a key role in the conversion of astrocytes into neurons (Buffo et al., 2005; Heins et al., 2002; Kronenberg et al., 2010) . In the ischemic brain, reactive astrocytes can be driven to reprogram and transdifferentiate into mature and functional neurons (Duan et al., 2015) , and this process is inhibited by notch (Magnusson et al., 2014) and enhanced by VEGF (Shen et al., 2016) . Here, we found that by double labeling for GFP and NeuN (Figure 5d ,e). In consistent with a previous study (Kronenberg et al., 2010) , exogenous PAX6 expression promoted the reprogramming of astrocytes towards neuronal differentiation. Remarkably, we also noticed that a portion of reprogrammed astrocytes could develop into mature neurons (Figure 6e,f) . Moreover, overexpression of PAX6 in the brain abolished the inhibitory effect of miR-365 on the astrocyte-to-neuron conversion (Figure 7e,f) . Collectively, our study suggests that increase of endogenous miR-365 in the brain enlarges infarct volume probably by inhibiting PAX6-mediated astrocyte-to-neuron conversion. Conversely, knockdown of miR-365 enhances the capacity of brain repair probably via promotion of PAX6-mediated astrocyte-to-neuron conversion. Our findings provide a novel insight into the mechanisms by which miRs regulate neurogenesis.
Recent findings have indicated that, in the ischemic brain, astrocytes participate in the remodeling of neurovascular units (Pan, Mao, & Sun, 2017; Shen et al., 2016) , which is an essential structure for functional brain repair (Lo, Dalkara, & Moskowitz, 2003; Lok et al., 2007) .
The present study reveals that miR-365 involves in this remodeling process. Knockdown of endogenous miR-365 or overexpression of PAX6 in the ischemic brain are favorable for the conversion of reactive astrocytes into neurons. It has been reported that these new neurons derived from astrocytes contribute to the reestablishment of functional neural circuitry (Duan et al., 2015) . Therefore, both miR-365 antagomir and PAX6 may become potential approaches to improve remodeling of astrocyte-neuron networks, a part of neurovascular units.
In summary, the current results demonstrate that the miR-365- 
